上海临床创新转化研究院副总裁王立言表示："诺和诺德在慢病领域拥有深厚的积累和前瞻性的布局， 上海临床创新转化研究院致力于搭建连接临床需求与产业创新的桥梁。我们相信，通过双方的战略合 作，将加速更多优秀临床成果惠及患者，为上海乃至中国医疗健康高质量发展注入强劲动能。" 诺和诺德全球高级副总裁周霞萍表示："植根中国31年，诺和诺德是中国医药生态系统创新的见证者、 参与者和贡献者。依托上海友好的营商环境以及对生物医药产业的体系化支持，我们期待，通过与上海 临转院的合作，扩展应对严重慢性疾病的生态圈，深度融入本土医药创新生态，为健康中国建设贡献力 量，也为全球医药创新注入中国智慧。"(经济日报记者袁勇) 11月6日，在第八届中国国际进口博览会现场，诺和诺德与上海临床创新转化研究院(以下简称"临转 院")签署战略合作协议，双方计划在临床研究与转化研究领域开展多方位合作和交流，加速助推上海临 床研究创新和成（002001）果转化，让创新疗法更快、更精准地服务于中国患者。 上海临床创新转化研究院(ACITS)是上海申康旗下专注促进临床创新与转化研究的专门机构。依托上海 高质量的医疗资源和诺和诺德百年创新药物研发经验，双方将 ...

Core Insights - The third Long Triangle High-Value Patent Operation Competition in the biomedicine (healthcare) sector was held in Nantong, showcasing 23 high-value patent projects from across the country, highlighting the innovation and market potential in China's biomedicine sector [1] Group 1: Event Overview - The event was guided by multiple intellectual property bureaus from Shanghai, Jiangsu, Zhejiang, and Anhui provinces, and co-hosted by various local organizations [1] - The competition featured projects in cutting-edge fields such as gene technology, AI-assisted diagnosis, high-end medical devices, innovative drugs, and marine biomedicine [1] Group 2: Awards and Recognition - Seven projects, including "Application of ECM1 in Liver Fibrosis" from the Chinese Academy of Sciences, won gold awards, while 12 projects, such as "A Handle-type Stent System" from Jiangsu Nuanyang Medical Device Co., received silver awards [1] Group 3: New Initiatives - The establishment of the Hushang Clinical Innovation Achievement Transformation Service Alliance was announced, aimed at bridging the entire "R&D - Clinical - Transformation" chain to accelerate the implementation of innovative results [1]